Fighting Bax: towards a Parkinson's disease therapy

Publisher： Elsevier

ISSN： 0166-2236

Source： Trends in Neurosciences, Vol.24, Iss.5, 2001-05, pp. : 255-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective Therapy for Parkinson's Disease

By Koller W.C.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Intravenous apomorphine therapy in Parkinson's disease

By Manson A.J.

Brain, Vol. 124, Iss. 2, 2001-02 ,pp. : 331-340

Oxford University Press

Access to resources Recommend Favorite

Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease

By Tatton N.A.

Experimental Neurology, Vol. 166, Iss. 1, 2000-11 ,pp. : 29-43

Elsevier

Access to resources Recommend Favorite

From Transplants to Gene Therapy for Parkinson's Disease

By Freeman T.B.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

Therapy for dyskinesias in Parkinson’s disease patients

By Stefani Alessandro Pierantozzi Mariangela Koch Giacomo Galati Salvatore Stanzione Paolo

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 277-299

Future Medicine

Access to resources Recommend Favorite